Article

Lymphomatoid Drug Reaction Secondary to Methylphenidate Hydrochloride

Author and Disclosure Information

Lymphomatoid drug reactions are relatively rare, with no gender, race, or age predilection. The condition generally may be divided into 2 broad categories with some overlap: (1) drug-induced pseudolymphoma and (2) anticonvulsant-induced pseudolymphoma syndrome, marked by the triad of papular to nodular skin lesions, fever, and lymphadenopathy. While a vast array of pharmacologic agents has been linked to lymphomatoid drug reactions, our case represents the first reported incidence of methylphenidate hydrochloride—a ubiquitously prescribed medication for attention deficit hyperactivity disorder—causing a pseudolymphoma.


 

Recommended Reading

Skating Along the Surface
MDedge Dermatology
Malignant Risk-Based SCC Classification Proposed
MDedge Dermatology
Pulsed Dye Laser Clears BCCs,Small Study Finds
MDedge Dermatology
All Patients Should Receive Complete Skin Exam
MDedge Dermatology
Merkel Cell Ulceration May Indicate Metastasis
MDedge Dermatology
Links Emerging Between Statins, NSAIDs, and Melanoma Prevention
MDedge Dermatology
Gene Transfer Shows Efficacy for Skin Lymphomas
MDedge Dermatology
Non-Hodgkin's Lymphoma Helped by Immunomodulator + Radiotherapy
MDedge Dermatology
Consider Melanoma Thickness Before Sentinel Node Biopsy
MDedge Dermatology
Pulsed-Light Device Allows for Home Hair Removal
MDedge Dermatology